Standard BioTools Inc.
LAB
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpā¦ read more
Healthcare
Diagnostics & Research
14 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.63
Price-1.81%
-$0.03
1Y
Price
Market Cap
$626.842m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-160.0%
EBITDA Margin-177.4%
Net Profit Margin-118.1%
Free Cash Flow MarginRevenue
$128.827m
-26.1%
1y CAGR+15.5%
3y CAGR+5.4%
5y CAGREarnings
-$128.251m
+7.7%
1y CAGR-5.9%
3y CAGR-59.6%
5y CAGREPS
-$0.34
+34.6%
1y CAGR+46.9%
3y CAGR-17.7%
5y CAGRBook Value
$399.659m
$539.636m
Assets$139.977m
Liabilities$27.389m
DebtDebt to Assets
5.1%
-0.3x
Debt to EBITDAFree Cash Flow
-$98.421m
+35.2%
1y CAGR-47.8%
3y CAGR-51.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company